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Abstract
Background: Diabetes is considered an independent risk factor for cognitive impairment and some studies
observed through neuropsychological tests that cognitive disfunction affects both elderly and younger patients
with diabetes. The aims of this study were to evaluate the cognitive status of outpatients with type 2 diabetes and
to evaluate factors associated with impaired function.
Methods: A cross-sectional study was conducted in a group of type 2 diabetic outpatients. They were asked to
undergo the Mini-Mental State Examination (MMSE) during routine ambulatory visits between April 2006 and
January 2007, with the highest pontuation of the test being 30 points. Patients were classified as having possible
dementia according to years of study. Exclusion criteria were blindness, illiterately, stroke, Alzheimer disease and
psychiatric disorder. Results are presented as median (interquartile range) or mean ± SD.
Results: The study group was composed of 346 type 2 diabetic outpatients (216 females), aged 58,6 ± 12,1 years
and with duration of diabetes of 12,3 ± 9,1 years. Hypertension was present in 77,2%. The total MMSE score
achieved was 26 points (16 - 30) and was correlated with years of study (R
2 = 0,39, p < 0,001) and ‘per capita’
income (R
2 = 0,22, p < 0,0001) and duration of diabetes (R2 = - 0,13, p = 0,01). Patients who needed help to take
their medications obtained worst performance in the MMSE (23,16 ± 3,55 vs 25,7 ± 2,84, p < 0,01) and were more
likely to present possible dementia (p < 0,01). Forty two subjects (12.1%) had diagnosis of possible dementia and
this was also associated with years of study (p = 0,045). No association was observed between possible dementia
and total MMSE scores with A1C levels.
Conclusions: We conclude that patients with type 2 diabetes should be regularly evaluated for their cognitive
function, because duration of disease could be associated with decline in cognition. The early implementation of
mini mental which is a simple method of execution can be done to detect early stages of dementia. This test
could be an important tool to access the ability of patient to understand their disease and treatment.
Background
The increasing prevalence of diabetes over the world has
become an important public health problem. Diabetes is
considered an epidemic disease nowadays, with about
173 million diabetic people over the world. As popula-
tion is increasing, getting older, more obese and seden-
tary, the number of individuals with diabetes also
increases. The population in Brazil is about 180 million
of people [1]. The last national study conducted in 1988
[2] observed a prevalence of diabetes of 7.6%. Recent
data in Brazil [3] estimated about 8 million patients
with diabetes.
Diabetes is the fifth cause of hospitalization and as an
underlying cause of death is among the ten major causes
of mortality in our country [4]. According to different
studies more than 50% of these patients will die from
cardiovascular disease (CVD) [5]. Besides diabetes, these
patients usually have other comorbidities, such as hyper-
tension, obesity and dyslipidemia. Today there is strong
evidence that supports an intensive control of glycemia,
blood pressure, cholesterol and weight to avoid cardio-
vascular and diabetes chronic complications, aiming to
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Due to the later events, patients have to change their
lifestyle and take many different pills to achieve a good
control of all parameters. These factors make it difficult
for patients who are not able to conduct theirselves or
have low educational and cognitive levels, which may
lead to an erroneous interpretation of prescription and,
as consequence, a poor adherence to treatment.
Although diabetes is considered to be risk factor for
cognitive impairment [8-11] the cognitive function of
patients with type 2 diabetes is not usually evaluated in
routine clinical care. Cognitive impairment might be
another factor associated with poor diabetes control and
also with bad adherence of patients to educational
approaches, such as diet orientations. Besides this, type 2
diabetes and dementia are common in the elderly [8,9],
which are often progressive and disabling conditions.
Some studies suggest that chronic hyperglycemia and
vascular alterations can cause damage to central nervous
system and lead to diabetes-related cognitive impairment
[12-14]. Beside this, a recent review showed considerable
evidences from the literature on the possible association
between type 2 diabetes with Alzheimer’s disease [15].
Dementia affects about 8% of all people older than 65
and has become the focus of many studies [16] and its
pathophisiology is still unknown. Among the neuropsy-
chological tests, the mini-mental state examination
(MMSE) is one of the most widely used screening tests.
This test which differentiates patients with non-specified
organic brain syndrome and depression from normal
individuals is also useful to estimate the severity of cog-
nitive impairment and in documenting serially cognitive
changes. The performance in the MMSE can be influ-
enced by age and education level [17-19], especially in
developing countries.
The aims of our study were to evaluate the cognitive
status of patients with type 2 diabetes and to evaluate
factors associated with impaired function detected by
MMSE.
Methods
A cross-sectional study was conducted in a group of 346
type 2 diabetic outpatients attended at the diabetes
clinic of the State University of Rio de Janeiro. Patients
were considered to have type 2 diabetes when diabetes
was diagnosed after 30 years of age, without insulin use
in the first year after the diagnosis and without history
of ketonuria.
Exclusion criteria were blindness, illiterately, stroke,
Alzheimer disease and psychiatric disorders. Patients
were asked to undergo the Mini-Mental State Examina-
tion (MMSE) during routine ambulatory visits between
April 2006 and January 2007.
Demographic characteristics such as sex, age, years of
study, ‘per capita’ income and duration of diabetes, and
medical history of hypertension, dyslipidemia, smoking,
and treatment of diabetes were assessed.
Hypertension was defined as systolic blood pressure
(sBP) ≥140 mmHg and/or diastolic blood pressure (dBP)
≥ 90 mmHg [20] or any value in patients under anti-
hypertensive treatment. Dyslipidemia was defined as
total cholesterol ≥ 200 mg/dl and/or HDL ≤ 45 mg/dl
and/or LDL ≥ 100 mg/dl and/or triglycerides ≥ 150 mg/
dl and/or use of statins or fibrates.
Smoker and former smoker were considered those
w h om a k eo rh a v em a d eu s eo fa n ya m o u n to fc i g a r -
ettes, respectively and were considered together in a
group of ever smokers.
Patients who need help to take their medications were
considered those who need a second person to adminis-
ter medications as prescribed.
Glycated Haemoglobin (A1c) was determined using a
high performance liquid chromatography (HPLC) refer-
ence value of 4 - 6.2%. FBG, triglyceride, HDL choles-
terol and total cholesterol levels were measured using
an auto-analyzer (Cobas-Mira Roche) with enzymatic
techniques. LDL cholesterol was calculated according to
Friedewald when triglycerides levels were less than 400
mg/Dl [21]. Weight and height were measured to the
nearest 0.1 Kg and 0.1 cm respectively. Body mass index
(BMI) (Kg/m
2) was calculated using these
measurements.
A standard MMSE form (22) was administered to each
of the 346 subjects. The MMSE scale ranges from 0 to
30 points, with higher number indicating better perfor-
mance. Instructions were identical for each subject.
The MMSE consists in 19 questions designed to assess
the patient’s mental status [21] in the following 5 cate-
gories: 10 orientations questions (year, season, date, day,
month, state, city, close street, floor and location); 2
memories items (repeat the words car, window and vase
and after delayed recall); 1 calculation item; 5 language
items (naming ‘watch-pencil’, repeat 3 words ‘No ifs,
ands, or buts’ (adapted to Portuguese language as ‘nem
aqui, nem ali, nem lá’), 3 step-command, read and fol-
low the sentence ‘close your eyes’ and write a sentence)
and 1 constructional item (copy overlapping pentagon)
(Appendix 1).
The stratification of the cut-off points was done in
accordance to years of study in order to prevent the
possibility of education level to mask the performance
in this test. We used a score system validated on Brazi-
lian population [22], with the following interpretation to
possible dementia: MMSE score < 26, if patient had
more than 8 years of study; MMSE score < 18 if patient
had between 1 and 8 years of study.
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The Kruskal-Wallis and Mann-Whitney U tests were used
for comparisons between groups of variables not normally
distributed and the Student t-test and ANOVA were used
for the other comparisons. ANCOVA was used for con-
trolling for the following variables (age, gender, duration
of diabetes, years of study, hypertension, dyslipidemia,
HbA1c). The Chi-square test with Yates correction was
used for comparison of categorical variables. Pearson cor-
relation and partial correlation controlling for the follow-
ing variables (age, gender, duration of diabetes, years of
study, hypertension, dyslipidemia, HbA1c) using Pearson’s
correlation coefficient was also performed.
These analyses were performed using the statistical
package for the social science (SPSS, version 13.0).
Values were expressed as mean (SD) or median (inter-
quartile range). A two-sided P value less than 0.05 was
considered to be significant.
Results
The study group was composed of 346 type 2 diabetic
outpatients (130 males, 216 females), aged 58.6 ± 12.1
years and with duration of diabetes of 12.3 ± 9.1 years.
Demographics and clinical characteristics of the patients
are shown in table 1. Fifty nine percent of patients had
between 8 or less years of study and 41% had more than
8 years.
Diet alone and one or more Oral Hypoglycemic
Agents (OHA) were the treatment of respectively 2%
and 56% of the diabetic patients. Insulin therapy alone
was seen in 19% and insulin plus one or more OHA in
23% of the patients studied. Most patients used 4 or
more drugs for the treatment for diabetes and comor-
bidities, corresponding to 71.8% of the sample. We did
not observe association between total number of drugs
used and glycemic control measured by A1c neither
with MMSE score.
T h em e a nt i m es p e n to np e rforming the MMSE test
was 16 minutes.
The mean total MMSE score was 26 points, with a
range from 16 to 30. Men presented higher MMSE
score than women (26.3 ± 3.2 vs 24.8 ± 2.7; p < 0.01),
and more years of study (9.2 ± 5.7 vs 7.2 ± 3.5; p =
0.001). The association between MMSE and gender per-
sisted after controlling for age (p = 0.001), HbA1c (p =
0.001), hypertension (0.001), dyslipidemia (p = 0.001)
and duration of diabetes (p = 0.001) In this model gen-
der and years of study have the same weight.
Patients who needed help to take their medications
obtained worst performance in the MMSE (23.16 ± 3.55
vs 25.7 ± 2.84, p < 0.0001) which persisted after control-
ling for age, gender, duration of diabetes, years of study,
hypertension, dyslipidemia, and HbA1c (p < 0.001 for
all). These patients were more likely to present possible
dementia (p < 0.01).
Diagnosis of hypertension and dyslipidemia were both
associated with total MMSE score (25.16 ± 3.05 vs 26.08
± 2.91, p = 0.014 and 25.16 ± 3.06 vs 26.08 ± 2.91 p =
0.014, respectively). The association with hypertension
persisted after controlling for age (p = 0.03), but not
after controlling for duration of diabetes (p = 0.07) and
years of study (p = 0.14). The association with dyslipide-
mia, persisted after controlling for age (p = 0.04) and
years of study, but not after controlling for duration of
diabetes (p = 0.055). The small number of patients with
dementia (n = 13) did not allow further analysis. There
was no association between smoking and score test.
No association was observed between possible demen-
tia and total MMSE scores with A1C levels.
A correlation was found between duration of the dia-
betes and the amount of points obtained in MMSE (r =
- 0.13; p = 0.01), that did not persist after controlling
for years of study (r = -0.08 p = 0.12), Further analysis
showed that the correlation between duration of dia-
betes and MMSE persisted after controlling for HbA1c
(r = - 0.14 p = 0.01), age (r = -0.13 p = 0.02), gender (r
= -0.11 p = 0.03), hypertension (r = -0.13 p = 0.01) and
dyslipidemia (r = -0.14 p = 0.01). The diagnosis of possi-
ble dementia was not associated with duration of the
disease.
The mean total MMSE score was correlated with
number of years of study (r = 0.39, p < 0.001). Forty
two subjects (12.1%) had diagnosis of possible dementia
and this was also associated with years of study (p =
0.045).
In our sample, number of years of study was corre-
lated with age (r = - 0.11; p = 0.03). There was no cor-
relation between age and score test. No quantitative
difference in score test was found between patients with
less (n = 279) or more (n = 65) than 70 years of age but
a qualitative difference was found. Patients older than
70 years had lower score when evaluated for ‘spatial
orientation’ (p = 0.034), ‘evocation of memory’ (p =
0.007) and ‘praxia’ ( p=0 . 0 3 8 )c o m p a r e dt oy o u n g e r
than 70 years.
Table 1 Demographic charactheristics of the patients
Total (n) 346
Female (n/%) 216/62.4%
Male (n/%) 130/37.6%
Age (years) 58,6 ± 12,1
Duration of diabetes (years) 12,3 ± 9,1
Years of study 7.58 ± 4.07
HbA1c (%) 7.92 ± 1.83
Hypertension (%) 77.2%
Dyslipidemia (%) 76.9%
Smokers (%) 9.2%
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of patients. A correlation was found between ‘per capita’
income and score test (r = 0.22; p < 0.0001).
Discussion
Diabetes is a chronic disease that leads to chronic long
term complications, including risk of cognitive changes.
In order to achieve intensive metabolic and blood pres-
sure control it is quite often necessary a complex pre-
scription, with several number of drugs. In this way, a
preserved cognitive status is essential to the understand-
ing of treatment and compliance.
In our study, we screened the mental state of patients
with type 2 diabetes through the mini mental status
examination.
MMSE may suffer influence of schooling [23,24],
which is of particular interest in developing countries.
According to this in our sample the total score achieved
in the test was greater in patients with higher education
level and patients classified as having possible dementia
had fewer years of study. Men had better performance
in the test and also had more years of study than
women.
Patients with longer duration of diabetes achieved
lower score test in agreement with other series [25,26].
Similar to other study [25] glycemic control measured
by A1C had no association with MMSE score and possi-
ble dementia in the evaluation period. It is important to
mention that we did not consider previous A1C values,
but only the A1C that has measured in the same year of
MMSE test. The above-mentioned fact did not permit
us to analyse glycemic control throughout the duration
of the disease. In contrast Reaven et al.d e m o n s t r a t e d
correlation between several measures of cognitive func-
tions and degree of hyperglycemia [27]. In this study,
with the same sample, they showed that the reduction
in A1C levels was associated to better cognitive perfor-
mance in elderly patients with type 2 diabetes [28].
The total number of drugs used by patients had no
association with glycemic control. This finding may
indicate that despite successive combinations of drugs
aiming to achieve good metabolic control it is important
to assess adherence to treatment. The ability of the
patient to understand the prescription and remember
the information provided during the appointment are
important to increase compliance to treatment. In addi-
tion, patients with possible dementia and lower scores
related need for assistance to take their medication.
This indicates the importance of greater attention to
these patients because cognitive deterioration leads to
impairment in self-management ability [29]. Despite we
did not find difference in the total MMSE score, our
patients older than 70 years presented worse perfor-
mance concerning memory evocation, which may
represent difficulty in incorporating information pro-
vided during a medical consultation.
Diabetes usually does not occur isolated. Hassing et al.
demonstrated that hypertension alone was not asso-
ciated to cognitive decline, but when combined to dia-
betes it increases the risk of cognitive impairment [30]
which is consistent to prior studies [31,32]. In our
study, patients with hypertension and dyslipidemia had
lower scores in the test, and it is known that these co
morbidities are related to atherosclerosis.
In our study, smoking was not associated to the punc-
tuation achieved on MMSE test. In contrast Arvanitakis
et al. found strong association of diabetes with cognitive
impairment in current smokers compared to those who
never smoked or formerly smoked.
Of the 346 patients who underwent the test, 42
(12.1%) were classified as presenting possible dementia.
Although our patients are younger than patients in
other studies and also young to assess possible diagnosis
of dementia, we found prevalence similar to others stu-
dies with older people [25,33]. This finding suggests that
diabetes could be a more important risk factor than age
in the development of cognitive dysfunction, even
though our study did not evaluate a control group to
assess the real impact of diabetes in cognitive function.
As above mentioned other factors, such as hypertension
and dyslipidemia may have influenced our results. How-
ever it is important to emphasize that both age of the
subjects and criteria used for diagnosis of possible
dementia are different between our study and the stu-
dies mentioned above which makes it difficult the com-
parison among them.
Much of our population lives in poor socioeconomic
conditions and a large contingent of Brazilians are illit-
erate or have low educational level. ‘Per capita’ income
can reflect socioeconomic status and in our country
people with better income have better educational level.
This might be the reason that in our sample lower ‘per
capita’ income has been linked to lower scores.
Our study has also some limitations. It’sk n o w nt h a t
physical activity has a significant impact on cognitive
function, with a study showing probable mediation of
insulin-related systems in the brain and skeletal muscles
[15]. First, we did not evaluate exercise and alcohol his-
tory. The investigation of some other factors including
smoking and years of study was based on self-report
which may have lead to recall bias. Second, as MMSE is
considered a screening test to evaluate dementia, we did
not use other methods to better evaluate or to confirm
this possible diagnosis. These tests such as magnetic
resonance are expensive and difficult to be used in rou-
tine clinical care. Third, given the socioeconomic status
of Brazilian patients, years of study do not necessarily
reflect a proper schooling.
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Patients with type 2 diabetes should be regularly evalu-
ated for their cognitive function, because duration of
disease could be associated with decline in cognition.
Based on the definition of health that is the wellness of
body, mind and social status; the maintenance of the
cognition should be chased as the protection of other
target-organs usually affected by diabetes, and are nor-
mally part of medical routine care. The early implemen-
tation of mini-mental, which is a simple method of
execution, can be done to detect early stages of demen-
tia. This test could be an important tool to access the
ability of patient to understand their disease and treat-
ment. Future studies will be important to better identify
risk factors for cognitive dysfunction and lighten its rela-
tionship with diabetes.
Appendix 1 - Mini-mental State Examination
10 orientations questions (year, season, date, Day,
month, state, country, city, floor and location) - 1 point
for each right question
1 memory item (delayed recall of car, pot, penny) - 1
point for each right question
1 item for Calculation: subtraction of seven serially
(100-7; 93-7; 86-7; 79-7; 72-7; 65)- 1 point for each cor-
rect calculation
6 language itens:
“watch-pencil” [naming] - 1 point each registration of
3 words (car, pot, penny) - 1 point each registration of
“No ifs, ands, or but” [repetition] - 1 point
3-step command [comprehension] - 1 point for each
step
“close your eyes” [reading] - 1 point
“write a sentence” [writing] - 1 point
1 constructional item (copy overlapping pentagons) -
1 point
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